Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan

Diabetic Medicine

Volumn 26, Issue 12, 2009, Pages 1255-1261

  Salti, I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Insulin glargine; Ramadan; Type 2 diabetes

Indexed keywords

GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RELIGION; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; ISLAM; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS;

EID: 70549102504     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02836.x     Document Type: Article

References (22)

1. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 2005 28 : 2305 2311.
2. Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004 27 : 2306 2311.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 1053.
4. Kadiri A. Profile of the fasting diabetic patient and nutrition during Ramadan. Pract Diab 1998 15 : S5 S6.
5. Chandalia HB, Bhargaav A, Kataria V. Dietary pattern during Ramadan fasting and its effect on metabolic control of diabetes. Pract Diab 1987 4 : 287 290.
6. Laajam MA. Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control. East Afr Med 1990 67 : 732 736.
7. Mafauzy M, Mohammed WB, Anum MY, Zulkifli A, Ruhani AH. A study of the fasting diabetic patients during the month of Ramadan. Med J Malaysia 1990 45 : 14 17.
8. Uysal AR, Erdòan MF, Sahin G, Karnel N, Erdòan G. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan. Diabetes Care 1998 21 : 2033 2034.
9. Mafauzy M. Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract 2002 58 : 45 53.
10. Bolli GB. Clinical strategies for controlling peaks and valleys: type 1 diabetes. Int J Clin Pract Suppl 2002 129 : 65 74.
11. Riddle MC, Rosenstock J, Gerich J. The treat to target trial. Diabetes Care 2003 26 : 3080 3086.
12. Skyler J, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE and VA Diabetes Trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 2009 119 : 351 357.
13. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 358 : 2545 2549.
14. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009 360 : 129 139.
15. Cesur M, Corapcioglu D, Gursoy A, Gonen S, Ozduman M, Emral R et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract 2007 75 : 141 147.
16. Ismail MMA, Alaswad M, Ejamail A, Abdelaziz K, Shawesh N, Dorar N et al. Metabolic control of type 2 diabetes using repaglinide during the fasting month of Ramadan. Diabetes Res Clin Pract 2003 50 : 71.
17. Anwar A, Azmi KN, Hamidon BB, Khalid BA. An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. Med J Malaysia 2006 61 : 28 35.
18. Akram J, De Verga V. Insulin lispro Lys(B28),Pro(B29) in the treatment of diabetes during the fasting month of Ramadan, Ramadan Study Group. Diabet Med 1999 16 : 861 866.
19. Mattoo V, Milicevic Z, Malone JK, Schwarzenhorfer M, Ekangaki A, Levitt LK et al. A comparison of insulin lispro Mix 25 and human insulin 30/70 in the treatment of type 2 diabetes mellitus during Ramadan. Diab Res Clin Pract 2003 59 : 137 143.
20. Kassem HS, Zantout MS, Azar ST. Insulin therapy during Ramadan fast for type 1 diabetes patients. J Endocrinol Invest 2005 28 : 802 805.
21. Kadiri A, Al-Nakhi A, El-Ghazali S, Jabbar A, Al Arouj M, Akram J et al. Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab 2001 27 : 482 486.
22. Mucha GT, Merkel S, Thomas W, Bantle JP. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care 2004 27 : 1209 1210.